Have a personal or library account? Click to login
Predictors associated with increased troponin in acute decompensated and chronic heart failure patients Cover

Predictors associated with increased troponin in acute decompensated and chronic heart failure patients

Open Access
|Apr 2021

References

  1. 1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer. J Am Coll Cardiol. 2017;70(6):776-803. DOI: 10.1016/j.jacc.2017.04.02510.1016/j.jacc.2017.04.025
  2. 2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cle-land JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016 Jul;37(27):2129-200. DOI: 10.1093/eurheartj/ehw12810.1093/eurheartj/ehw128
  3. 3. Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’Connor C, Felker GM, et al. Troponin Elevation in Heart Failure- Prevalence, Mechanisms, and Clinical Implications. J Am Coll Cardiol. 2010;56(14):1071-8. DOI: 10.1016/j.jacc.2010.06.01610.1016/j.jacc.2010.06.016
  4. 4. La Vecchia L, Mezzena G, Ometto R, Finocchi G, Bedogni F, Soffiati G, et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol. 1997;80(1):88-90. DOI: 10.1016/S0002-9149(97)00291-910.1016/S0002-9149(97)00291-9
  5. 5. Missov E, De Marco T. Clinical insights on the use of highly sensitive cardiac troponin assays. Clin Chim Acta. 1999 Jun;284(2):175-85. DOI: 10.1016/S0009-8981(99)00079-010.1016/S0009-8981(99)00079-0
  6. 6. Januzzi JL, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: On behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Vol. 33, European Heart Journal. 2012. p. 2265-71. DOI: 10.1093/eurheartj/ehs19110.1093/eurheartj/ehs19122745356
  7. 7. Diez M, Talavera ML, Conde DG, Campos R, Acosta A, Trivi MS, et al. High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiol J. 2016;23(1):78-83. DOI: 10.5603/CJ.a2015.005810.5603/CJ.a2015.005826412605
  8. 8. Shah KS, Maisel AS, Fonarow GC. Troponin in Heart Failure. Heart Fail Clin. 2018;14(1):57-64. DOI: 10.1016/j.hfc.2017.08.00710.1016/j.hfc.2017.08.00729153201
  9. 9. Carlsson AC, Bandstein N, Roos A, Hammarsten O, Holzmann MJ. High-sensitivity cardiac troponin T levels in the emergency department in patients with chest pain but no myocardial infarction. Int J Cardiol. 2017;228:253-9. DOI: 10.1016/j.ijcard.2016.11.08710.1016/j.ijcard.2016.11.08727865194
  10. 10. Gore MO, Seliger SL, Christopher R, Nambi V, Christenson RH, Hashim IA, et al. Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T Assay. 2014;63(14):1441-8. DOI: 10.1016/j.jacc.2013.12.03210.1016/j.jacc.2013.12.032398490024530665
  11. 11. Bargnoux A, Kuster N, Moréna M, Baptista G, Chenine L, Badiou S, et al. L ‘ âge et la fonction rénale sont-ils des limites à l ‘ interprétation des biomarqueurs cardiaques ? Ann Biol Clin. 2016;74(4):413-9. DOI: 10.1684/abc.2016.116510.1684/abc.2016.116527492694
  12. 12. Ndumele C, Cobb L, Lazo M, Bello N, Shah A, Nambi V, et al. Weight History and Subclinical Myocardial Damage. Clin Chem. 2019;64(1):201-9. DOI: 10.1373/clinchem.2017.28279810.1373/clinchem.2017.282798621937629158254
  13. 13. Zheng J, Ye P, Luo L, Xiao W, Xu R, Wu H, et al. Association between blood glucose levels and high-sensitivity cardiac troponin T in an overt cardiovascular disease-free community-based study. Diabetes Res Clin Pract. 2012;97(1):139-45. DOI: 10.1016/j.diabres.2012.04.02110.1016/j.diabres.2012.04.02122579531
  14. 14. Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, et al. Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation : An ARISTOTLE Substudy. 2015;61:368-78. DOI: 10.1373/clinchem.2014.22693610.1373/clinchem.2014.22693625451868
  15. 15. Chen M, Gerson H, Eintracht S, Nessim SJ, Macnamara E. Effect of Hemodialysis on Levels of High-Sensitivity Cardiac Troponin T. Am J Cardiol. 2017;120(11):2061-4. DOI: 10.1016/j.amjcard.2017.08.02610.1016/j.amjcard.2017.08.02629033047
  16. 16. Kirkman DL, Muth BJ, Ramick MG, Townsend RR, Edwards DG. Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease. Am J Physiol Ren Physiol. 2018;314:423-9. DOI: 10.1152/ajprenal.00321.201710.1152/ajprenal.00321.2017589922229117995
  17. 17. Cai Q, Mukku VK, Ahmad M. Coronary Artery Disease in Patients with Chronic Kidney Disease : A Clinical Update. 2013;(Mi):331-9. DOI: 10.2174/1573403X10 66614021412223410.2174/1573403X10666140214122234
  18. 18. Santhanakrishnan R, Chong JPC, Ng TP, Ling LH, Sim D, Leong KTG, et al. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs . reduced ejection fraction. Eur J Heart Fail. 2012;14:1338-47. DOI: 10.1093/eurjhf/hfs13010.1093/eurjhf/hfs13022869458
  19. 19. Pandey A, Golwala H, Sheng S, DeVore AD, Hernandez AF, Bhatt DL, et al. Factors associated with and prognostic implications of cardiac troponin elevation in decompensated heart failure with preserved ejection fraction: Findings from the American Heart Association Get With the Guidelines-Heart Failure program. JAMA Cardiol. 2017;2(2):136-45. DOI: 10.1001/jamacardio.2016.472610.1001/jamacardio.2016.472628030747
  20. 20. Löwbeer C, Gustafsson S, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest. 2004;64:667-76. DOI: 10.1080/0036551041000300210.1080/0036551041000300215513324
  21. 21. Jarolim P. High sensitivity cardiac troponin assays in the clinical laboratories. 2015;53(5):635-52. DOI: 10.1515/cclm-2014-056510.1515/cclm-2014-056525252753
  22. 22. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May;150(9):604-12. DOI: 10.7326/0003-4819-150-9-200905050-0000610.7326/0003-4819-150-9-200905050-00006276356419414839
  23. 23. Pascual-Figal D, Casas T, Ordonez-Llanos J, Manzano-Fernández S, Bonaque J, Boronat M, et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J. 2012;163(6):1002-10. DOI: 10.1016/j.ahj.2012.03.01510.1016/j.ahj.2012.03.01522709753
  24. 24. Felker GM, Hasselblad V, Tang WHW, Hernandez AF, Armstrong PW, Fonarow GC, et al. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail. 2012 Nov;14(11):1257-64. DOI: 10.1093/eurjhf/hfs11010.1093/eurjhf/hfs11022764184
  25. 25. Rustamova Y, Dobreanu D. Biomarkers in heart failure: From the bedside back to biology. Rev Rom Med Lab. 2018 Jul;26(3):267-70. DOI: 10.2478/rrlm-2018-003110.2478/rrlm-2018-0031
  26. 26. Harrison N, Favot M, Levy P. The Role of Troponin for Acute Heart Failure. Curr Heart Fail Rep. 2019;16(1):21-31. DOI: 10.1007/s11897-019-0420-510.1007/s11897-019-0420-530762176
  27. 27. Hickman PE, Potter JM, Aroney C, Koerbin G, South-cott E, Wu AHB, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Vol. 411, Clinica Chimica Acta. Elsevier; 2010. p. 318-23. DOI: 10.1016/j.cca.2009.12.00910.1016/j.cca.2009.12.00920036224
  28. 28. Park KC, Gaze DC, Collinson PO, Marber MS. Cardiac troponins: From myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708-18. DOI: 10.1093/cvr/cvx18310.1093/cvr/cvx183585261829016754
  29. 29. Lee K, Ferry A, Anand A, Strachan F, Chapman A, Kimenai D, et al. Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome. J Am Coll Cardiol. 2019;74(16):2032-43. DOI: 10.1016/j.jacc.2019.07.08210.1016/j.jacc.2019.07.082687627131623760
  30. 30. Fu S, Ping P, Zhu Q, Ye P, Luo L. Brain natriuretic peptide and its biochemical, analytical, and clinical issues in heart failure: A narrative review. Vol. 9, Frontiers in Physiology. Frontiers Media S.A.; 2018. p. 692. DOI: 10.3389/fphys.2018.0069210.3389/fphys.2018.00692599606629922182
  31. 31. Bettencourt P. NT-proBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail. 2004 Mar;6(3):359-63. DOI: 10.1016/j.ejheart.2004.01.00810.1016/j.ejheart.2004.01.00814987589
  32. 32. Long B, Belcher CN, Koyfman A, Bronner JM. Interpreting Troponin in Renal Disease: A Narrative Review for Emergency Clinicians. Am J Emerg Med. 2020;38(5):990-7. DOI: 10.1016/j.ajem.2019.11.04110.1016/j.ajem.2019.11.04131831340
  33. 33. Jeremias A, Gibson CM. Narrative review: Alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Vol. 142, Annals of Internal Medicine. American College of Physicians; 2005. p. 786-91. DOI: 10.7326/0003-4819-142-9-200505030-0001510.7326/0003-4819-142-9-200505030-0001515867411
  34. 34. Kanderian AS, Francis GS. Cardiac troponins and chronic kidney disease. Vol. 69, Kidney International. Kidney Int; 2006. p. 1112-4. DOI: 10.1038/sj. ki.500017410.1038/sj.ki.5000174
  35. 35. Kida K, Hattori K, Ishii T, Motegi T, Kusunoki Y, Gemma A, et al. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015 Feb;10(1):309-320. DOI: 10.2147/COPD.S7629310.2147/COPD.S76293433003125709425
  36. 36. Campo G, Pavasini R, Malagù M, Mascetti S, Biscaglia S, Ceconi C, et al. Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management. Cardiovasc Drugs Ther. 2015 Apr;29(2):147-57. DOI: 10.1007/s10557-014-6569-y10.1007/s10557-014-6569-y25645653
  37. 37. Rydén L, Roos A, Holzmann MJ. Chronic Myocar-dial Injury and Risk for Stroke. Am J Med. 2019 Jul;132(7):833-9. DOI: 10.1016/j.amjmed.2019.01.02710.1016/j.amjmed.2019.01.02730716296
  38. 38. Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, et al. Determinants of troponin release in patients with stable coronary artery disease: Insights from CT angiography characteristics of athero-sclerotic plaque. Heart. 2011 May;97(10):823-31. DOI: 10.1136/hrt.2010.19320110.1136/hrt.2010.19320120884786
DOI: https://doi.org/10.2478/rrlm-2021-0015 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 153 - 164
Submitted on: Feb 13, 2021
Accepted on: Mar 7, 2021
Published on: Apr 27, 2021
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Anamaria Draghici, Catalin Adrian Buzea, Caterina Delcea, Ancuta Vijan, Gheorghe Andrei Dan, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.